Gregory M. Weinhoff, Chief Business Officer at Centessa Pharmaceuticals plc (CNTA), sold 33,238 shares at $15.69 ($522K) on 2024-09-25, disclosed to the SEC on 2024-09-27.
Scheduled sale ($522k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.69 | 16,619 | $261K | 50.0% |
| 2 | $15.69 | 16,619 | $261K | 50.0% |
| Total | $15.69 avg | 33,238 | $522K | 100% |
| Filing → |
| CNTA | SELL | 2025-07-25 | $156K | — | Filing → |
| CNTA | SELL | 2025-06-25 | $139K | — | Filing → |
| CNTA | SELL | 2025-05-27 | $128K | — | Filing → |